Compile Data Set for Download or QSAR
Report error Found 210 of affinity data for UniProtKB/TrEMBL: O90785
TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514108(US11052087, Compound 1)
Affinity DataEC50:  4.62nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514109(US11052087, Compound 2)
Affinity DataEC50:  56.6nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514111(US11052087, Compound 3)
Affinity DataEC50:  603nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514113(US11052087, Compound 4)
Affinity DataEC50:  5.71E+3nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514114(US11052087, Compound 5)
Affinity DataEC50:  1.14E+3nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514115(US11052087, Compound 6)
Affinity DataEC50:  278nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514116(US11052087, Compound 7)
Affinity DataEC50:  247nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514117(US11052087, Compound 8)
Affinity DataEC50:  102nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514118(US11052087, Compound 9)
Affinity DataEC50:  20.6nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM514120(US11052087, Compound 14)
Affinity DataEC50:  6.54nMAssay Description:Compounds were tested in a high-throughput 384-well assay format for their ability to inhibit the replication of HIV-1 (IIIB) in MT-4 cells. Compound...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720791(US20250051375, Compound 1)
Affinity DataEC50:  7.60nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720792(US20250051375, Compound 2)
Affinity DataEC50:  2.10nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720793(US20250051375, Compound 3)
Affinity DataEC50:  96.6nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720794(US20250051375, Compound 4)
Affinity DataEC50:  20.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720795(US20250051375, Compound 5)
Affinity DataEC50:  73.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720796(US20250051375, Compound 6)
Affinity DataEC50:  20.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720797(US20250051375, Compound 7)
Affinity DataEC50:  23.2nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720798(US20250051375, Compound 8)
Affinity DataEC50:  230nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720799(US20250051375, Compound 9)
Affinity DataEC50:  241nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720800(US20250051375, Compound 10)
Affinity DataEC50:  418nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720801(US20250051375, Compound 11)
Affinity DataEC50:  577nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720802(US20250051375, Compound 12)
Affinity DataEC50:  23.4nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720803(US20250051375, Compound 13)
Affinity DataEC50:  223nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720804(US20250051375, Compound 14)
Affinity DataEC50:  178nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720805(US20250051375, Compound 15)
Affinity DataEC50:  162nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720806(US20250051375, Compound 16)
Affinity DataEC50:  62.2nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720807(US20250051375, Compound 17)
Affinity DataEC50:  170nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720808(US20250051375, Compound 18)
Affinity DataEC50:  251nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720809(US20250051375, Compound 19)
Affinity DataEC50:  38.9nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720810(US20250051375, Compound 20)
Affinity DataEC50:  0.700nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720811(US20250051375, Compound 21)
Affinity DataEC50:  3.60nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720812(US20250051375, Compound 22)
Affinity DataEC50:  9.90nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720813(US20250051375, Compound 23)
Affinity DataEC50:  204nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720814(US20250051375, Compound 24)
Affinity DataEC50:  130nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720815(US20250051375, Compound 25)
Affinity DataEC50:  62.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720816(US20250051375, Compound 26)
Affinity DataEC50:  96.9nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720817(US20250051375, Compound 27)
Affinity DataEC50:  173nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720818(US20250051375, Compound 28)
Affinity DataEC50:  307nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720819(US20250051375, Compound 29)
Affinity DataEC50:  213nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720820(US20250051375, Compound 30)
Affinity DataEC50:  197nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720821(US20250051375, Compound 31)
Affinity DataEC50:  276nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720822(US20250051375, Compound 32)
Affinity DataEC50:  137nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720823(US20250051375, Compound 33)
Affinity DataEC50:  65.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720824(US20250051375, Compound 34)
Affinity DataEC50:  179nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720825(US20250051375, Compound 35)
Affinity DataEC50:  65.7nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720826(US20250051375, Compound 36)
Affinity DataEC50:  97.4nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720827(US20250051375, Compound 37)
Affinity DataEC50:  41.8nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720828(US20250051375, Compound 38)
Affinity DataEC50:  305nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720829(US20250051375, Compound 39)
Affinity DataEC50:  64.4nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

TargetHIV-1 protease(Human immunodeficiency virus)
Gilead Sciences

US Patent
LigandPNGBDBM720830(US20250051375, Compound 40)
Affinity DataEC50:  40.5nMAssay Description:Test compounds and controls were serially diluted and spotted in replicate into 384 well black assay plates via acoustic transfer (Echo). MT-4 cells ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/17/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 210 total ) | Next | Last >>
Jump to: